Hepatitis B Virus Infection Market
Hepatitis B is potentially a life-threatening liver infection caused by the Hepatitis B Virus (HBV). It is a major global health problem and it can be an acute infection or a chronic infection. Chronic HBV infection is a leading cause of chronic hepatitis and advanced-stage liver diseases, including cirrhosis and hepatocellular carcinoma (HCC).

-HBV Infection is estimated to have 786,000 deaths and the vast majority being attributable to liver cancer (341,000 deaths) and cirrhosis (312,000 deaths), as per [Lozano et al., 2012].
-According to the WHO, about 2 billion people worldwide have been infected with the Hepatitis B Virus and about 360 million live with chronic Hepatitis B infection.
-The global prevalence of HBV infection varies widely.
-HBV infection ranks 15th among all causes of human mortality [Lozano et al., 2012]
-The global prevalence of HBV infection varies widely. It ranges from <0.5 % in areas of low endemicity (e.g., North America and some Western European countries) to rates above 8% in the highly endemic countries of Sub-Saharan Africa and East Asia.

For more details, visit:
https://www.delveinsight.com/report-store/hepatitis-b-virus-hbv-infection-market